Vigil Neuro (VIGL) - Company Net Income

Official company branding of vigilneuro.com (VIGL)

Consistent leadership and investor support drive the gross profit dynamics of Vigil Neuroscience (VIGL), as illustrated by this GURU.Markets chart, where the current value is -0.09. The business operates through centers in Massachusetts, developing immunological therapies for neuronal restoration. High scalability is secured by molecular patents, which will enable the company to establish pricing power while maintaining low production costs.

VIGL Vigil Neuroscience Inc. Net Profit (07/04/2022 - 08/16/2025)

Analytical breakdowns and data insights for company vigilneuro.com (VIGL)

- stock value and consensus price forecast:
Market Price Vigil Neuroscience, Inc.|VIGL - Consensus Target
- market capitalization indicators:
Market Value Vigil Neuroscience, Inc.|VIGL - Enterprise Value
- book capitalization indicators:
Net Assets per Share Vigil Neuroscience|VIGL - Book Capitalization|Market Value to Equity Ratio vigilneuro.com|VIGL - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Vigil Neuroscience|VIGL - Long-Term Debt to Equity|Short-Term Debt to Equity Vigil Neuroscience, Inc.|VIGL - Company Total Debt|Debt to Net Assets Ratio Vigil Neuroscience, Inc.|VIGL - Company Long-Term Debt|Company Short-Term Indebtedness Vigil Neuroscience|Immediate Liquidity vigilneuro.com
- earnings and multiples data:
VIGL - Net Income
Summary company analysis:Vigil Neuro (VIGL)
Mass-produced product of Vigil Neuroscience, Inc.

The high scalability of Vigil Neuroscience (VIGL) biopharmaceutical developments in the rare neurological disease segment creates potential for a sharp surge in margins upon drug commercialization. This metric digitizes the final financial result for the period, allowing for the mathematical expectation of returns to be captured and the risks of catastrophic drawdowns relative to average values to be assessed through an analysis of the company's net profit.

Main competitors

Company Net Income Biogen Idec (BIIB)|Net Income NBIX|Company Net Income RGC|Net Profit AXSM|Net Financial Result ACADIA Pharma|Net Profit XENE (Xenon Pharmaceuticals Inc)|Annual Net Income Viking Therapeutics Corp|Supernus Pharmaceuticals - Net Profit|Net Financial Result catalystpharma.com CPRX|Denali Therapeutics Inc. (DNLI) - Company Net Income|HRMY (Harmony Biosciences Inc) - Company Net Income|Net Income BHVN|AMLX: Final Profit|Company Net Income Trevi Therapeutics (TRVI)|praxismedicines.com - Company Profit|Net Profit AVXL (Anavex Life Sciences Corp.)|CeriBell Inc (CBLL) - Company Net Income|PRTA: Net Income|ALEC - Net Profit|Annexon, Inc. (ANNX) - Company Net Income|Omeros - Final Profit|Company Net Income Neurogene|Company Net Income AC Immune S.A. ACIU|Company Net Income Voyager Pharma (VYGR)|Net Financial Result Neumora Corp|Net Profit SCLX (Scilex Holding Company)|TVGN - Net Income|Alpha Cognition Corp - Net Profit|Net Financial Result cogrx.com CGTX|IKT: Net Profit|Company Net Income Cassava Pharma (SAVA)|Company Net Income Assertio Holdings|Company Profit COYA (Coya)|Net Profit VTGN|Net Income ovidrx.com OVID|Net Profit ABOS (Acumen Pharma)|CervoMed Corporation (CRVO) - Company Net Income|ATHE: Net Income|CLNN: Company Net Income|PEPG: Net Profit|JUNS - Net Financial Result|RLMD (Relmada) - Net Profit|ANVS - Annual Net Income|Company Net Income Grace Therapeutics, Inc. (GRCE)|Company Net Income AIFF (fireflyneuro.com)|Company Net Income Klotho Neurosciences KLTO|NRSN: Company Profit|Reviva Pharmaceuticals Holdings - Net Profit|Company Net Income MetaVia Inc|NRXS (NeurAxis, Inc.) - Net Income|Helius Medical Technologies (HSDT) - Net Profit|Company Net Income Passage Bio Inc.|NEUP: Final Profit|Company Net Income Minerva Neurosciences Corp (NERV)|ATHA - Company Net Income|Addex Therapeutics - Net Income|Alzamend Neuro Inc. - Company Net Income|Cyclerion - Net Profit|Net Financial Result Protagenic Therapeutics PTIX|KTTA: Net Profit|Annual Net Income Cortigent CRGT|ATXI (Avenue Therapeutics) - Net Profit|brainstorm-cell.com (BCLI) - Net Financial Result|Company Net Income Cara Therapeutics (CARA)|Company Net Income CHRO (Chromocell Therapeutics Corp)|Eliem Therapeutics Inc. - Net Income|Final Profit ITCI|LBPH - Company Net Income|MRNS (marinuspharma.com) - Company Profit|NKGN: Net Profit|Company Net Income NeuroBo Pharmaceuticals Inc (NRBO)|Net Income SAGE|Net Profit Synaptogenix, Inc|Company Net Income Trevena, Inc. (TRVN)|WENA (Anew Medical Inc.) - Final Profit|Company Net Income Cerevel Therapeutics, Inc. CERE